Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine
- 1 January 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 135 (2) , 564-578
- https://doi.org/10.1038/sj.bjp.0704479
Abstract
Behavioural and pharmacological effects of Δ9‐tetrahydrocannabinol (THC) and nicotine are well known. However, the possible interactions between these two drugs of abuse remain unclear in spite of the current association of cannabis and tobacco in humans. The present study was designed to analyse the consequences of nicotine administration on THC‐induced acute behavioural and biochemical responses, tolerance and physical dependence. Nicotine strongly facilitated hypothermia, antinociception and hypolocomotion induced by the acute administration of THC. Furthermore, the co‐administration of sub‐threshold doses of THC and nicotine produced an anxiolytic‐like response in the light–dark box and in the open‐field test as well as a significant conditioned place preference. Animals co‐treated with nicotine and THC displayed an attenuation in THC tolerance and an enhancement in the somatic expression of cannabinoid antagonist‐precipitated THC withdrawal. THC and nicotine administration induced c‐Fos expression in several brain structures. Co‐administration of both compounds enhanced c‐Fos expression in the shell of the nucleus accumbens, central and basolateral nucleus of the amygdala, dorso‐lateral bed nucleus of the stria terminalis, cingular and piriform cortex, and paraventricular nucleus of the hypothalamus. These results clearly demonstrate the existence of a functional interaction between THC and nicotine. The facilitation of THC‐induced acute pharmacological and biochemical responses, tolerance and physical dependence by nicotine could play an important role in the development of addictive processes. British Journal of Pharmacology (2002) 135, 564–578; doi:10.1038/sj.bjp.0704479Keywords
This publication has 81 references indexed in Scilit:
- The paradox of nicotinic acetylcholine receptor upregulation by nicotinePublished by Elsevier ,2002
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Δ9‐tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effectEuropean Journal of Neuroscience, 2001
- D2 dopamine receptors enable Δ9‐tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentrationBritish Journal of Pharmacology, 2000
- Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food rewardPublished by Elsevier ,2000
- Modulation by fluoxetine of striatal dopamine release following Δ9‐tetrahydrocannabinol: a microdialysis study in conscious ratsBritish Journal of Pharmacology, 1999
- Δ9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidancePublished by Elsevier ,1998
- Cannabis: pharmacology and toxicology in animals and humansAddiction, 1996
- Distribution of preproenkephalin, preprotachykinin A, and preprodynorphin mRNAs in the rat nucleus accumbens: Effect of repeated administration of nicotineSynapse, 1996
- Molecular and Cellular Aspects of Nicotine AbusePublished by Elsevier ,1996